Data as of November 21, 2026

Rivastigmine 9.5 mg/24HR Patch

RIVASTIGMINE

Brand: Rivastigmine

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$55.99/ fill$1.75 / EA
Cost Plus Drugs (retail)
$30.58/ fill$0.96 / EA
FUL
$97.47/ fill$3.05 / EA
AMP
$55.70/ fill$1.74 / EA
Medicaid FFS
$57.81/ fill
Medicaid MCO
$184.58/ fill

Sources: cms/nadac:price-ladder · costplusdrugs/price-list · cms/ful:generic-ceiling · cms/sdud. Cost Plus prices as of 2026-11-21

What's in the reimbursement

Ingredient cost (32 units/fill)$55.99
Dispensing fee & other (state-fixed, not margin)$1.82
Total reimbursed per fill$57.81

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 6 fee-for-service states, 2 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-11-11; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology